PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- EBITDA, 2025
- −$157M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$157M | — |
| 2024 | $254M | — |
| 2023 | −$93M | — |
| 2022 | −$130M | — |
| 2021 | −$125M | — |
| 2020 | −$64M | — |
| 2019 | −$80M | — |
| 2018 | −$42M | — |
| 2017 | −$37M | — |
| 2016 | −$32M | — |
| 2015 | −$15M | — |
| 2014 | −$9.1M | — |